Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs
Authors:
- 23 October 2008
- journal article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 24 (12) , 3435-3442
Abstract
Objective: To assess the association between adherence with fluticasone propionate/salmeterol combination (FSC) product in a single inhaler and asthma care utilization and costs in asthma patients in typical US clinical practice.Methods: Retrospective longitudinal analysis using linked medical and pharmacy claims from a managed care database representing >70 US health plans. Subjects included those with two prescriptions for FSC after January 1, 2000 (first prescription = ‘index date’) and diagnosis of asthma. Follow-up was defined as time from index date to disenrollment or discontinuation of FSC (180 days without supply), receipt of different controller, or 24 months post-index. Patients were excluded if: <12 months continuous enrollment pre-index, <12 months of follow-up, diagnoses of COPD or respiratory cancer, use of ipratropium, or age <12 years. Effect of FSC adherence on asthma-related outcomes (short-acting beta-agonist use (SABA), corticosteroid use (CS), emergency department (ED) visit/...Keywords
This publication has 21 references indexed in Scilit:
- Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthmaClinical Therapeutics, 2008
- Rationale for the major changes in the pharmacotherapy section of the National Asthma Education and Prevention Program guidelinesJournal of Allergy and Clinical Immunology, 2007
- A Checklist for Medication Compliance and Persistence Studies Using Retrospective DatabasesValue in Health, 2007
- Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthmaThorax, 2005
- Adherence to MedicationNew England Journal of Medicine, 2005
- Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapiesJournal of Allergy and Clinical Immunology, 2004
- Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthmaThorax, 2002
- Two-Year Retrospective Economic Evaluation of Three Dual-Controller Therapies Used in the Treatment of AsthmaChest, 2002
- Low-Dose Inhaled Corticosteroids and the Prevention of Death from AsthmaNew England Journal of Medicine, 2000
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992